From: Are bacterial coinfections really rare in COVID-19 intensive care units?
Antibiotics | n (%) |
---|---|
Piperacillin–tazobactam | 37 (28) |
Teicoplanin | 52 (40) |
Meropenem | 78 (60) |
Colistin | 41 (32) |
Fosfomycin | 8 (6) |
Antipseudomonal Cephalosporins | 6 (5) |
Tigecycline | 5 (4) |
Others | 22 (17) |